Efficiency and Safety of the Selective Relaxant Binding Agent Adamgammadex Sodium for Reversing Rocuronium-Induced Deep Neuromuscular Block: A Single-Center, Open-Label, Dose-Finding, and Phase IIa Study.
Frontiers in Medicine（2021）
Key words
neuromuscular blocking agents,phase IIa study,adamgammadex,selective relaxant binding agents,dose-finding clinical trials
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined